HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intracervical instillation of PGE2-gel in patients with missed abortion or intrauterine fetal death.

Abstract
A single intracervical instillation of prostaglandin E2 (1.0 mg or 0.5 mg in viscous gel) was given to dilate the cervix before dilatation and evacuation in patients with missed abortion or intrauterine fetal death in late pregnancy. The 1.0-mg dose of PGE2 gave more prominent cervical dilatation in early pregnancy. In late pregnancy 1.0 mg PGE2 induced labor in the majority of patients and with shorter induction delivery time than in patients given 0.5 mg PGE2. There was no uterine hypertonus and no patients complained of gastrointestinal symptoms. We conclude that intracervical instillation of 1.0 mg of PGE2 in viscous gel is a safe and effective method both for dilating the cervix before dilatation and evacuation and as a method of inducing labor in patients with intrauterine fetal death.
AuthorsG Ekman, N Uldbjerg, L Wingerup, U Ulmsten
JournalArchives of gynecology (Arch Gynecol) Vol. 233 Issue 4 Pg. 241-5 ( 1983) ISSN: 0170-9925 [Print] Germany
PMID6660917 (Publication Type: Journal Article)
Chemical References
  • Prostaglandins E
Topics
  • Abortion, Missed (drug therapy)
  • Administration, Topical
  • Cervix Uteri
  • Female
  • Fetal Death
  • Humans
  • Labor, Induced
  • Pregnancy
  • Prostaglandins E (administration & dosage, therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: